Predict your next investment

The Column Group company logo
Venture Capital
FINANCE | Asset/Financial Management
thecolumngroup.com

See what CB Insights has to offer

Investments

112

Portfolio Exits

22

Funds

7

About The Column Group

The Column Group is a venture capital firm dedicated to creating biotechnology companies.

The Column Group Headquarter Location

1700 Owens Street Suite 500

San Francisco, California, 94158,

United States

415-865-2050

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing The Column Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find The Column Group in 1 Expert Collection, including CB Insights Healthcare Smart Money Investors - 2020.

C

CB Insights Healthcare Smart Money Investors - 2020

25 items

Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.

The Column Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

The Column Group Rank

Research containing The Column Group

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned The Column Group in 4 CB Insights research briefs, most recently on Feb 16, 2021.

Latest The Column Group News

NGM Biopharmaceuticals stock climbs 10% on insider buying

May 16, 2022

NGM Biopharmaceuticals (NASDAQ: NGM ) stock climbed as much as 10.2% on Monday after the firm disclosed certain insider buying . NGM disclosed that director and 10% owner Column Group bought ~166.4K shares at $10.73-$11.99 worth ~$1.9M in multiple transactions. Column Group now holds ~11.1M shares in NGM. Take a look at NGM's ownership structure: NGM stock has fallen ~30% YTD. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

The Column Group Investments

112 Investments

The Column Group has made 112 investments. Their latest investment was in Remix Therapeutics as part of their Series B on May 5, 2022.

CBI Logo

The Column Group Investments Activity

investments chart

The Column Group Portfolio Exits

22 Portfolio Exits

The Column Group has 22 portfolio exits. Their latest portfolio exit was Entrada Therapeutics on October 29, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/29/2021

IPO

$99M

Public

7

7/30/2021

IPO

$99M

Public

4

5/27/2021

Acq - Pending

$99M

2

4/15/2021

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

8/14/2020

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2021

7/30/2021

5/27/2021

4/15/2021

8/14/2020

Exit

IPO

IPO

Acq - Pending

Acq - Pending

Divestiture

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

7

4

2

10

10

The Column Group Fund History

7 Fund Histories

The Column Group has 7 funds, including PONOI CAPITAL.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2017

PONOI CAPITAL

Early-Stage Venture Capital

Closed

1

4/27/2016

Column Group III

Subscribe to see more

Subscribe to see more

$99M

10

4/27/2016

Column Group III-A

$99M

10

9/16/2014

Column Group II

Subscribe to see more

Subscribe to see more

$99M

10

4/30/2008

Column Group LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/31/2017

4/27/2016

4/27/2016

9/16/2014

4/30/2008

Fund

PONOI CAPITAL

Column Group III

Column Group III-A

Column Group II

Column Group LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

The Column Group Team

7 Team Members

The Column Group has 7 team members, including current Managing Partner, David V. Goeddel.

Name

Work History

Title

Status

David V. Goeddel

Managing Partner

Current

Tim Kutzkey

Managing Partner

Current

Peter H. Svennilson

Three Crowns Capital, and Nomura Holdings

Managing Partner

Current

Jeffrey Baxter

Managing Partner

Former

Harald Ekman

Three Crowns Capital, Goldman Sachs, and Nomura Holdings

Managing Partner

Former

Name

David V. Goeddel

Tim Kutzkey

Peter H. Svennilson

Jeffrey Baxter

Harald Ekman

Work History

Three Crowns Capital, and Nomura Holdings

Three Crowns Capital, Goldman Sachs, and Nomura Holdings

Title

Managing Partner

Managing Partner

Managing Partner

Managing Partner

Managing Partner

Status

Current

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.